SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-007693
Filing Date
2023-05-09
Accepted
2023-05-09 18:24:04
Documents
1
Period of Report
2023-05-05

Document Format Files

Seq Description Document Type Size
1 form4-05092023_100556.html 4  
1 form4-05092023_100556.xml 4 5978
  Complete submission text file 0001415889-23-007693.txt   7529
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20725 S. WESTERN AVENUE SUITE 136 TORRANCE CA 90501
Business Address
Miyashita Akiko Moni (Reporting) CIK: 0001607742 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 23903722